Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus (MOMS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01821508|
Recruitment Status : Active, not recruiting
First Posted : April 1, 2013
Last Update Posted : February 23, 2018
Hospital Alemão Oswaldo Cruz
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by (Responsible Party):
MD Ricardo Victor Cohen, Hospital Alemão Oswaldo Cruz
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||April 2021|
|Estimated Study Completion Date :||May 2021|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Cohen RV, Pereira TV, Aboud CM, Caravatto PP, Petry TB, Correa JL, Schiavon CA, Correa M, Pompílio CE, Pechy FN, le Roux CW; MOMS Study Investigators. Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial. BMJ Open. 2017 Jan 11;7(1):e013574. doi: 10.1136/bmjopen-2016-013574. Erratum in: BMJ Open. 2017 Apr 22;7(4):e013574corr1.